Showing results (11-20 of 92) with videos related to
Sort By:
Pageof 10
Journal of Leukocyte Biology|April 3, 2002
Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophagesGeert Raes, Patrick De Baetselier, Wim Noël, et al.Frontiers in Immunology|November 25, 2022
Applications of nanobodies in brain diseasesFang Zheng, Yucheng Pang, Luyao Li, et al.Cellular Immunology|April 18, 2018
The role of hepatic macrophages in liver metastasisJiri Keirsse, Helena Van Damme, Xenia Geeraerts, et al.Developmental Immunology|August 2, 2003
FIZZ1 and Ym as tools to discriminate between differentially activated macrophagesGeert Raes, Wim Noël, Alain Beschin, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Nitric oxide-independent CTL suppression during tumor progression: association with arginase-producing (M2) myeloid cellsYuanqing Liu, Jo A Van Ginderachter, Lea Brys, et al.Blood|October 24, 2002
Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generationAnja B Geldhof, Jo A Van Ginderachter, YuanQing Liu, et al.Pharmaceuticals (Basel, Switzerland)|June 2, 2021
68Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET TracersHenri Baudhuin, Julie Cousaert, Philippe Vanwolleghem, et al.International Journal of Cancer|August 28, 2007
The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomasGeert Raes, Gholamreza Hassanzadeh Ghassabeh, Lea Brys, et al.Frontiers in Immunology|August 1, 2020
Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer ImmunotherapyEls Lebegge, Sana M Arnouk, Pauline M R Bardet, et al.Immunobiology|August 14, 2012
Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancerSteve Schoonooghe, Damya Laoui, Jo A Van Ginderachter, et al.Pageof 10